RT @yusuke_mazda: 臨床使用する上で,カルベトシンの利点は,投与法のバリエーションが少ない事. カルベトシン→効果がない→すぐに次のステップに進む オキシトシン→効果がない→オキシトシン増量?子宮筋注?etc.→時間の浪費 ただ,一般的に言われる100mc…
RT @ayako700: 【弛緩出血に対する収縮薬】2018年に引きつづき、2021年のネットワークメタアナリシスでも、カルベトシンが有利! 早く日本でもカルベトシンが使えるようになってほしい(出血が母体死亡の1位なのに、なぜ承認されないのだろうか) コクラン https…
臨床使用する上で,カルベトシンの利点は,投与法のバリエーションが少ない事. カルベトシン→効果がない→すぐに次のステップに進む オキシトシン→効果がない→オキシトシン増量?子宮筋注?etc.→時間の浪費 ただ,一般的に言われる100mcgは予定帝切では多過ぎる.
RT @ayako700: 【弛緩出血に対する収縮薬】2018年に引きつづき、2021年のネットワークメタアナリシスでも、カルベトシンが有利! 早く日本でもカルベトシンが使えるようになってほしい(出血が母体死亡の1位なのに、なぜ承認されないのだろうか) コクラン https…
RT @ayako700: 【弛緩出血に対する収縮薬】2018年に引きつづき、2021年のネットワークメタアナリシスでも、カルベトシンが有利! 早く日本でもカルベトシンが使えるようになってほしい(出血が母体死亡の1位なのに、なぜ承認されないのだろうか) コクラン https…
RT @ayako700: 【弛緩出血に対する収縮薬】2018年に引きつづき、2021年のネットワークメタアナリシスでも、カルベトシンが有利! 早く日本でもカルベトシンが使えるようになってほしい(出血が母体死亡の1位なのに、なぜ承認されないのだろうか) コクラン https…
RT @ayako700: 【弛緩出血に対する収縮薬】2018年に引きつづき、2021年のネットワークメタアナリシスでも、カルベトシンが有利! 早く日本でもカルベトシンが使えるようになってほしい(出血が母体死亡の1位なのに、なぜ承認されないのだろうか) コクラン https…
【弛緩出血に対する収縮薬】2018年に引きつづき、2021年のネットワークメタアナリシスでも、カルベトシンが有利! 早く日本でもカルベトシンが使えるようになってほしい(出血が母体死亡の1位なのに、なぜ承認されないのだろうか) コクラン https://t.co/nvuUXHVkQ9 2021 https://t.co/s1MMId4t8w https://t.co/ntGJ6S9Fyx
@Ron_George @GongGasGirl @NavSidhu08 For us, carbetocin is about 3 times more expensive than an oxytocin bolus + infusion (including fluids/lines). Mostly there’s confidence in the dec 2018 cochrane update with marginal benefit for carbetocin. https://t.co
RT @rincondesisifo: (Evidently Cochrane) Fármacos uterotónicos para prevenir las hemorragias postparto https://t.co/3YZ3R35KrM Comentario d…
(Evidently Cochrane) Fármacos uterotónicos para prevenir las hemorragias postparto https://t.co/3YZ3R35KrM Comentario de revisión https://t.co/Jxd18jozqH Revisión original https://t.co/nK9TKFc4u6 Guía de la OMS actualizada https://t.co/mIrsqujufm
RT @unibirm_MDS: Find out more about the innovative research that @IoannisGallos @IMSR_UoB is doing on reproduction, early #pregnancy and #…
Find out more about the innovative research that @IoannisGallos @IMSR_UoB is doing on reproduction, early #pregnancy and #maternalhealth. You can read the #CochraneReview online https://t.co/vkZwqd3Hml https://t.co/VX1N4lvZoE
"O objectivo desta revisão foi descobrir qual é o tratamento + eficaz e com - efeitos colaterais para evitar a perda excessiva de sangue depois do parto (...)". #CochranePortugal #MaisEvidencia #MelhorSaude https://t.co/e6DQNCfb9c
RT @IIRRMedicine: Which drug is most effective in preventing excessive blood loss at childbirth? A network meta‐analysis and @WHO updated…
RT @IIRRMedicine: Which drug is most effective in preventing excessive blood loss at childbirth? A network meta‐analysis and @WHO updated…
Which drug is most effective in preventing excessive blood loss at childbirth? A network meta‐analysis and @WHO updated guidance to help prevent #postpartumhaemorrhage #PPH #Cochranereview https://t.co/g35s0BHu2s
Carbetocina presenta ventajas sobre la oxitocina para prevenir hemorragias postparto. https://t.co/5R3TV4lE70
RT @BlameOxytocin: Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. https://t.co/TP2l0HEW2N
RT @BlameOxytocin: Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. https://t.co/TP2l0HEW2N
Thanks @arricoomarasamy for inviting me into this great team. Delighted to have played my small part!
RT @ammalife: Very proud of the many Ammalife Changemakers and research partners who have achieved this. Thank you for all you do to make m…
RT @BlameOxytocin: Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. https://t.co/TP2l0HEW2N
RT @BlameOxytocin: Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. https://t.co/TP2l0HEW2N
RT @BlameOxytocin: Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. https://t.co/TP2l0HEW2N
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. https://t.co/TP2l0HEW2N
Very proud of the many Ammalife Changemakers and research partners who have achieved this. Thank you for all you do to make motherhood safer.👏🏽👏🏽👏🏽
RT @Drbalamk: Which uterotonic is the best to prevent blood loss in mothers after childbirth- we may finally have an answer to this life sa…
RT @Drbalamk: Which uterotonic is the best to prevent blood loss in mothers after childbirth- we may finally have an answer to this life sa…
RT @Drbalamk: Which uterotonic is the best to prevent blood loss in mothers after childbirth- we may finally have an answer to this life sa…
RT @DrMiffyWilliams: It has been an absolute pleasure to work with @IoannisGallos and @oladapo_olufemi on this review and guideline https:/…
RT @Drbalamk: Which uterotonic is the best to prevent blood loss in mothers after childbirth- we may finally have an answer to this life sa…
RT @Drbalamk: Which uterotonic is the best to prevent blood loss in mothers after childbirth- we may finally have an answer to this life sa…
Which uterotonic is the best to prevent blood loss in mothers after childbirth- we may finally have an answer to this life saving question- https://t.co/UUIIfx4L0c @arricoomarasamy @amiewil @DavidLissauer @Sepsis_FASTM @abimerriel @wparrysmith @crustymcrus
It has been an absolute pleasure to work with @IoannisGallos and @oladapo_olufemi on this review and guideline
Network linked in. Revised @WHO guidance on uterotonics for bleeding after childbirth https://t.co/tnqwDTERwi drew on this updated @CochranePCG #NetworkMetaAnalaysis https://t.co/uQs1TYezQ2